Wnt/beta-catenin signaling pathway: a target for novel therapeutic approaches in multiple myeloma

Gast, Sanna-Marie; Kim, Y.; Schmidt‐Wolf, Ingo G.H.

doi:10.1358/dof.2013.038.11.2058449

Drugs Fut

2013

DOI: 10.1358/dof.2013.038.11.2058449

|View full text |Cite

Wnt/beta-catenin signaling pathway: a target for novel therapeutic approaches in multiple myeloma

Sanna-Marie Gast¹,

Y. Kim²,

Ingo G.H. Schmidt‐Wolf³

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Other1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Microbes to Man: From Soils and the Depths to Drugs

Newman¹

2021

Burger's Medicinal Chemistry and Drug Discovery

View full text Add to dashboard Cite

This article covers microbially sourced antibiotics and anticancer agents that have either been approved by regulatory agencies (US and EU), are awaiting approval or are generally in Phases I–Phase III (cancer) or Phase I–IV (antibiotics). Also included are discussions of compounds that have been “developed” by synthetic chemists using as their templates, materials originally from microbes. Included are discussions on developments with genetic analyses of as yet uncultured (perhaps unculturable in the case of some symbionts), including use of environmental DNA (eDNA) as routes to novel agents where the microbe is unknown, even “unknowable.” In addition, examples are given of how agents that are too toxic to act as pharmaceutical agents in their own right, have now become major components of novel treatments for cancer treatment by linking these “toxins” to monoclonal antibodies directed to particular epitopes on cancerous cells, thus delivering highly toxic and effective agents directly to the site(s) needed. Comments have also been made about the lack of new antimicrobials, in particular directed toward fungal infections and the ESKAPE pathogen series, where agents long out of use, are now acting as templates upon which to design novel potent compounds.

show abstract

Microbes to Man: From Soils and the Depths to Drugs

Newman¹

2021

Burger's Medicinal Chemistry and Drug Discovery

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Wnt/beta-catenin signaling pathway: a target for novel therapeutic approaches in multiple myeloma

Cited by 1 publication

References 0 publications

Microbes to Man: From Soils and the Depths to Drugs

Microbes to Man: From Soils and the Depths to Drugs

Contact Info

Product

Resources

About